Medical/Pharmaceuticals
Lipidor AB licence agreement grants Menarini Group company, RELIFE Srl, exclusive rights to register, promote, distribute and market two new psoriasis drug candidates for potential value of MEUR 70
STOCKHOLM, Sweden, July 2, 2021 /PRNewswire/ -- Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announced today that it has signed a licence agreement under which Lipidor grants RELIFE S.r.l., part of leading international pharmaceutical company, Menarini Group, exclusive rights to re...
2021-07-02 05:32
2473
Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany
SEOUL, South Korea, July 1, 2021 /PRNewswire/ -- A Phase 1 study on new drug candidate IDG16177 of novel oral treatment for type 2 diabetes, which is being developed by Ildong Pharmaceutical, is initiated inGermany. On June 28th (local time), Ildong Pharmaceutical obtained approval for the Phas...
2021-07-01 21:00
2651
Bactiguard receives payment from Zimmer Biomet
STOCKHOLM, July 1, 2021 /PRNewswire/ -- Following successful European regulatory clearance and market launch of Bactiguard-coated Zimmer Biomet trauma implants (ZNN Bactiguard), the initialUSD 1 million milestone payment has been released. "I am excited about our partnership with Zimmer Biomet a...
2021-07-01 17:47
1790
InDevR Launches VaxArray Polio Kit for Faster, Multiplexed Vaccine Characterization
BOULDER, Colo., July 1, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Polio D-antigen quantification kit for r...
2021-07-01 15:00
1829
Elliott Publishes Letter on GlaxoSmithKline
Elliott believes GSK has a substantial value creation opportunity – 45% upside in its share price – ahead of Consumer Health separation and greater beyond Despite its strengths, GSK has a poor record of operational execution and value creation, leading to scepticism about the Company's future, an...
2021-07-01 14:45
2188
European Wellness partners with China's provincial government to advance Education in Biological Regenerative Medicine
EDENKOBEN, Germany, July 1, 2021 /PRNewswire/ – European Wellness Biomedical Group (European Wellness) through its educational arm, European Wellness Academy (EWA), has signed a Letter of Intent (LOI) withZhifu People's Government of Yantai City,Shandong Province, China to establish the first In...
2021-07-01 08:00
4901
Joint Commission International publishes fourth edition of International Accreditation Standards for Laboratories
Standards and policies in latest edition become effective 1 January 2022 OAK BROOK, Ill., July 1, 2021 /PRNewswire/ -- Joint Commission International (JCI) today publishedJoint Commission International Accreditation Standards for Laboratories, Fourth Edition. The manual provides requirements for ...
2021-07-01 08:00
2136
Zimmer Biomet announces partnership with OSSIS as exclusive Asia Pacific distributor for patient-specific 3D printed titanium hip replacement joints
SINGAPORE, July 1, 2021 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a partnership with OSSIS to serve as the exclusiveAsia Pacific distributor for its patient-specific 3D printed titanium hip replacement joints. ...
2021-07-01 08:00
6024
Antheia Announces $73M Series B to Commercialize Synthetic Biology Platform for Essential Medicines
Led by Viking Global Investors, the Series B round will be used to bring Antheia's first pharmaceutical compounds to market, expand its pipeline and scale production in global markets MENLO PARK, Calif., June 30, 2021 /PRNewswire/ -- Antheia, a synthetic biology company enabling next-generation ...
2021-06-30 20:00
2711
Mentice receives order of total SEK 5.9 million from Baylis Medical Company
STOCKHOLM, June 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on interventional procedures, has entered into an agreement withBaylis Medical Company ("Baylis")to provide simulation solutions. Based on t...
2021-06-30 18:19
1755
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine Candidate
* Clover to procure CpG 1018 adjuvant from Dynavax for use in the commercial production of Clover's COVID-19 vaccine candidate, SCB-2019 (CpG 1018/Alum) * Pending conditional regulatory approvals, Clover expects to commence product launch of SCB-2019 (CpG 1018/Alum) by the end of 2021 CHENGDU,...
2021-06-30 16:00
6119
Clover Announces Advance Purchase Agreement with Gavi for Over 400 Million Doses of Clover's COVID-19 Vaccine for the COVAX Facility
* Pending WHO EUL for its COVID-19 vaccine candidate, Clover is committed to providing 64 million doses in 2021 and Gavi has options for an additional 350 million doses in 2022 * Clover will receive a significant upfront payment, a payment upon positive Phase 2/3 data, potential payments upon...
2021-06-30 16:00
3149
Mentice appoints Gunilla Andersson as Chief Financial Officer (CFO)
STOCKHOLM, June 30, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on image guided interventions,appoints Gunilla Andersson as CFO, effective September 1st, 2021. Mentice AB is pleased to announce the appoin...
2021-06-30 15:06
1878
Envirotainer Greets China Airlines as the latest airline to approve the new Releye® RLP container
STOCKHOLM, June 30, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that China Airlines has approved the Envirotainer Releye® RLP for usage on their aircrafts. With this approval, China Airlines ...
2021-06-30 14:48
2316
Bioinduction Announces the World's First Successful Implantations of 'PICOSTIM', a Novel, Less Invasive, Self-Contained Cranialized 'Brain Pacemaker' for Parkinson's Disease
Small, smart, single-stage skull implanted DBS system can be implanted in under half the time of conventional implantations BRISTOL, England, June 30, 2021 /PRNewswire/ -- Bioinduction Ltd., a company developing an innovative and disruptive patient-centric Deep Brain Stimulation (DBS) platform s...
2021-06-30 14:00
1605
New Welch Allyn® PanOptic™ Plus Ophthalmoscope and Welch Allyn® MacroView® Plus Otoscope Give Caregivers Better, Bolder, Brighter Views
SINGAPORE, June 30, 2021 /PRNewswire/ -- Hillrom today announced major technological advances to its market-leading physical assessment tools with the launch of the new Welch Allyn® PanOptic™ Plus Ophthalmoscope and the Welch Allyn® MacroView® Plus Otoscope. The new devices represent advancements...
2021-06-30 09:15
6348
Subcutaneously Injected PD-L1 Antibody Envafolimab (KN035) Obtained Its Second Orphan Drug Designation From The U.S. FDA
SUZHOU, China, June 30, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to envafolimab (KN035), a recombinant humanized PD-L1 single-domain antibody independently invented by Alphamab Onco...
2021-06-30 08:55
9537
GSK Singapore and Vir Biotechnology Announce Advance Purchase Agreement with the Government of Singapore for Monoclonal Antibody Sotrovimab (VIR-7831)
* GSK Singapore has signed an Advance Purchase Agreement with the Government ofSingapore for sotrovimab * Sotrovimab is currently undergoing review by the Singapore Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR) for interim authorization * Announcement follow...
2021-06-30 06:30
3151
Cynosure Celebrates 30 Years of Innovation
Aesthetics leader recognizes milestone with focus on future skin aesthetics innovation to help reveal the Beautiful Energy within everyone WESTFORD, Mass., June 29, 2021 /PRNewswire/ -- Since 1991, Cynosure has been a leader in the beauty aesthetics space, creating a comprehensive range of exper...
2021-06-29 21:00
2234
European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
Partnership builds on complementary strengths to advance research in melanoma with a focus on Stage 2 melanoma patients BRUSSELS and CASTRES, France, June 29, 2021 /PRNewswire/ -- European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic part...
2021-06-29 20:13
2438
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 305 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 303 media titles]
2026-05-19 23:59
Hong Leong Bank Awarded Best Managed Bank in Malaysia by The Asian Banker, Group MD/CEO Kevin Lam Named Best Bank CEO in Malaysia
[Picked up by 293 media titles]
2026-05-15 17:00
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 289 media titles]
2026-05-18 15:30
AIMX Singapore 2026 Anchors Strategic Relationship with TechInnovation and AI Gravity
[Picked up by 279 media titles]
2026-05-19 14:00
Most Read
H World Group Reports Q1 Results, Highlighting Asset-light Growth and Expanding APAC Footprint
2026-05-15 20:11
7715
